[KROS] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
10-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -11.89%
YoY- -239.14%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
Revenue 8 0 0 2,500 2,500 -76.19%
PBT -39,440 -23,509 -20,335 -12,036 -3,549 82.50%
Tax -210 -4,467 -38 -156 -1,217 -35.52%
NP -39,440 -19,042 -20,297 -12,036 -3,549 82.50%
Tax Rate - - - - - -
Total Cost 39,448 19,042 20,297 14,536 6,049 59.75%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
NP Margin -493,000.00 0.00 0.00 -481.44 -141.96 666.59%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
EPS -1.33 -0.75 -0.87 -0.60 -0.40 35.00%
EPS Diluted -1.33 -0.75 -0.87 -0.60 -0.40 35.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.